eli lilly retatrutide buy ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide, Eli Lilly's next generation

In patients not using positive airway pressure therapy, tirzepatide reduced the AHI by 27.4 events per hour, compared to 4.8 with placebo (55% reduction)

But firstthis edition is proudly brought to you by Light-it

The FDA has not approved any over-the-counter microneedle patch containing GLP-1 or semaglutide for weight loss

As the market transitions from shortage-driven supply to long-term commercial growth, demand for advanced drug delivery devices and pharmaceutical packaging solutions will continue to increase

So I believe other factors are at play besides losing weight. David Greenberg, MD, FACP MNT spoke with Lauren Carcas, MD, a medical oncologist with Miami Cancer Institute, part of Baptist Health South Florida, about this studys findings, who commented that while theyre exciting, the data must be interpreted in context